| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.1083558 |
| P953 | full work available at URL | https://syndication.highwire.org/content/doi/10.1126/science.1083558 |
| P3181 | OpenCitations bibliographic resource ID | 57157 |
| P698 | PubMed publication ID | 12702876 |
| P5875 | ResearchGate publication ID | 10797813 |
| P50 | author | Rudolf Jaenisch | Q90073 |
| P2093 | author name string | Heinrich Leonhardt | |
| Amir Eden | |||
| Joe W. Gray | |||
| François Gaudet | |||
| Laurie Jackson-Grusby | |||
| J. Graeme Hodgson | |||
| Jessica Dausman | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene | Q22011158 | ||
| Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals | Q22122053 | ||
| Targeted mutation of the DNA methyltransferase gene results in embryonic lethality | Q28131773 | ||
| Transcription of IAP endogenous retroviruses is constrained by cytosine methylation | Q29618745 | ||
| Hypomethylation distinguishes genes of some human cancers from their normal counterparts | Q29619217 | ||
| Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability | Q29620365 | ||
| DNA hypomethylation leads to elevated mutation rates | Q34752442 | ||
| DNA methylation in cancer: too much, but also too little | Q34770545 | ||
| Reactivating the expression of methylation silenced genes in human cancer | Q34770617 | ||
| Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus | Q34997520 | ||
| The 5-methylcytosine content of DNA from human tumors | Q35689206 | ||
| DNA methylation and genetic instability in colorectal cancer cells | Q36049856 | ||
| Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues | Q37679466 | ||
| DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair | Q39674490 | ||
| Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation | Q40834659 | ||
| Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis | Q41351086 | ||
| 5-Methylcytosine content of nuclear DNA during chemical hepatocarcinogenesis and in carcinomas which result | Q41668069 | ||
| Rearrangement of c-myc, pim-1 and Mlvi-1 and trisomy of chromosome 15 in MCF- and Moloney-MuLV-induced murine T-cell leukemias | Q43821654 | ||
| Integration of Moloney leukaemia virus into the germ line of mice: correlation between site of integration and virus activation | Q45791002 | ||
| Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas | Q46369286 | ||
| A short DNA methyltransferase isoform restores methylation in vivo. | Q50741462 | ||
| Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. | Q52201995 | ||
| Suppression of intestinal neoplasia by DNA hypomethylation. | Q54613769 | ||
| Analysis of early initiating event(s) in radiation-induced thymic lymphomagenesis. | Q54968940 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Chromosomal Instability and Tumors Promoted by DNA Hypomethylation | Q63253103 | ||
| X chromosome-linked transmission and expression of retroviral genomes microinjected into mouse zygotes | Q71233909 | ||
| An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome | Q72228831 | ||
| Control of V(D)J recombinational accessibility of the D beta 1 gene segment at the TCR beta locus by a germline promoter | Q77328514 | ||
| P433 | issue | 5618 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chromosome abnormality | Q744962 |
| DNA methylation | Q874745 | ||
| P304 | page(s) | 489-92 | |
| P577 | publication date | 2003-04-18 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Induction of tumors in mice by genomic hypomethylation | |
| Induction of Tumors in Mice by Genomic Hypomethylation | |||
| P478 | volume | 300 |
| Q36696150 | 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation |
| Q34581149 | 3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell models |
| Q33670566 | 5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer? |
| Q39263507 | A DNA methyltransferase modulator inspired by peyssonenyne natural product structures. |
| Q47264910 | A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation |
| Q36394208 | A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro |
| Q37090752 | A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer |
| Q34487211 | A cross-sectional study of global DNA methylation and risk of colorectal adenoma |
| Q37374166 | A dose-response study of arsenic exposure and global methylation of peripheral blood mononuclear cell DNA in Bangladeshi adults |
| Q34142430 | A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results |
| Q36206457 | A gene expression signature identifying transient DNMT1 depletion as a causal factor of cancer-germline gene activation in melanoma |
| Q34438078 | A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer |
| Q34077410 | A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome |
| Q55346622 | A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer. |
| Q33808550 | A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers |
| Q61454317 | A study of meiomitosis and novel pathways of genomic instability in cutaneous T-cell lymphomas (CTCL) |
| Q35962455 | AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome |
| Q40908304 | APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma. |
| Q49668158 | Aberrant DNA Methylation in Colorectal Cancer: What Should We Target? |
| Q35560819 | Aberrant DNA methylation and prostate cancer |
| Q30494652 | Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model |
| Q36393854 | Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer. |
| Q26738706 | Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development? |
| Q24301060 | Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells |
| Q36753304 | Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer |
| Q36600205 | Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. |
| Q50087550 | Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing. |
| Q51579160 | Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. |
| Q27001209 | Active DNA demethylation of the vertebrate genomes by DNA methyltransferases: deaminase, dehydroxymethylase or demethylase? |
| Q37850732 | Advancements in reprogramming strategies for the generation of induced pluripotent stem cells |
| Q34106626 | Advances in reprogramming somatic cells to induced pluripotent stem cells |
| Q35075323 | Age- and pregnancy-associated DNA methylation changes in mammary epithelial cells. |
| Q33771976 | Age-associated epigenetic modifications in human DNA increase its immunogenicity |
| Q46971058 | Aging in heterozygous Dnmt1-deficient mice: effects on survival, the DNA methylation genes, and the development of amyloidosis |
| Q49196932 | All Things in Moderation: Prevention of Intestinal Adenomas by DNA Hypomethylation. |
| Q92633975 | Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer |
| Q53331392 | Alteration of mitogen-activated protein kinase pathway after soman poisoning. |
| Q35643414 | Altered LINE-1 Methylation in Mothers of Children with Down Syndrome. |
| Q47562973 | Alu siRNA to increase Alu element methylation and prevent DNA damage |
| Q59351330 | An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications |
| Q41593205 | An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients |
| Q24623823 | An overview of epigenetics and chemoprevention |
| Q36674063 | Analysis of APC mutation in human ameloblastoma and clinical significance |
| Q42794721 | Analysis of O6-methylguanine-DNA methyltransferase methylation status in sporadic colon polyps. |
| Q42726197 | Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. |
| Q36485572 | Applying whole-genome studies of epigenetic regulation to study human disease |
| Q37437220 | Association between global DNA hypomethylation in leukocytes and risk of breast cancer |
| Q42182618 | Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC). |
| Q28534409 | Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma |
| Q54288218 | Association of BLCA-4 hypomethylation in blood leukocyte DNA and the risk of bladder cancer in a Chinese population. |
| Q35301805 | Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma |
| Q49234966 | Attenuation of genome-wide 5-methylcytosine level is an epigenetic feature of cutaneous malignant melanomas. |
| Q33851073 | Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity |
| Q24298913 | BRCA1 affects global DNA methylation through regulation of DNMT1 |
| Q38642565 | Back and forth in time: Directing age in iPSC-derived lineages. |
| Q99546378 | Bacteria-related changes in host DNA methylation and the risk for CRC |
| Q35916793 | Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies |
| Q42738037 | Biological functions of DNA methyltransferase 1 require its methyltransferase activity |
| Q34405013 | Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation |
| Q34436694 | Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population |
| Q36000279 | Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells. |
| Q27694164 | Breast cancer epigenetics: from DNA methylation to microRNAs |
| Q39974031 | CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery. |
| Q39426075 | Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins |
| Q29615524 | Cancer epigenomics: DNA methylomes and histone-modification maps |
| Q36871595 | Cancer genetics of epigenetic genes |
| Q34155181 | Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus |
| Q38221517 | Causes and Consequences of Age-Related Changes in DNA Methylation: A Role for ROS? |
| Q38062512 | Cellular reprogramming and cancer development |
| Q53185114 | Cellular reprogramming technology for dissecting cancer epigenome in vivo. |
| Q35583494 | Cell‐cycle regulation of T‐cell responses – novel approaches to the control of alloimmunity |
| Q33863925 | Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer |
| Q34151239 | Characteristics of replication-independent endogenous double-strand breaks in Saccharomyces cerevisiae |
| Q36706884 | Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease |
| Q35190160 | Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms |
| Q27003401 | Chromatin dynamics during cellular reprogramming |
| Q34256428 | Chromatin replication and epigenome maintenance |
| Q37027185 | Chromatin structure and DNA double-strand break responses in cancer progression and therapy. |
| Q37810688 | Chromatin: a molecular interface between cancer and aging |
| Q53236379 | Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma. |
| Q36019105 | Chromosomal instability in oral cancer cells. |
| Q28756307 | Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally |
| Q29618090 | Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells |
| Q38154781 | Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer |
| Q26864051 | Common features of chromatin in aging and cancer: cause or coincidence? |
| Q37014343 | Comparative Epigenomic Profiling of the DNA Methylome in Mouse and Zebrafish Uncovers High Interspecies Divergence |
| Q48215153 | Comparative analysis of DNA methylation patterns of equine sarcoid and healthy skin samples. |
| Q31164904 | Comparisons of brain, uterus, and liver mRNA expression for cytochrome p450s, DNA methyltransferase-1, and catechol-o-methyltransferase in prepubertal female Sprague-Dawley rats exposed to a mixture of aryl hydrocarbon receptor agonists |
| Q90228357 | Conflicts of CpG density and DNA methylation are proximally and distally involved in gene regulation in human and mouse tissues |
| Q35843804 | Connections between epigenetic gene silencing and human disease |
| Q28080961 | Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome |
| Q37682358 | Contribution of epigenetic mechanisms to variation in cancer risk among tissues. |
| Q38508141 | Contribution of epigenetics in diabetic retinopathy |
| Q33420388 | Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer |
| Q44557536 | Correlation between global genome methylation and mutation at CpG codons of p53 gene |
| Q33617224 | Could Sirt1-mediated epigenetic effects contribute to the longevity response to dietary restriction and be mimicked by other dietary interventions? |
| Q43274890 | CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma |
| Q36950422 | CpG islands: their potential as biomarkers for cancer |
| Q36795579 | Cross Talk Mechanism among EMT, ROS, and Histone Acetylation in Phorbol Ester-Treated Human Breast Cancer MCF-7 Cells |
| Q34608782 | Curcumin modulates DNA methylation in colorectal cancer cells. |
| Q37371733 | Current progress in epigenetic research for hepatocarcinomagenesis |
| Q40235196 | Cytogenetic characteristics of a murine in vitro model for the human anaplastic large cell lymphoma (ALCL). |
| Q36378140 | Cytosine methylation and hydroxymethylation mark DNA for elimination in Oxytricha trifallax |
| Q37883042 | Cytosine methyltransferases as tumor markers |
| Q91708347 | DNA Methylation Cancer Biomarkers: Translation to the Clinic |
| Q36113662 | DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID |
| Q35623184 | DNA Methylation and Flavonoids in Genitourinary Cancers |
| Q49627540 | DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis. |
| Q39389314 | DNA Methylation, Nuclear Organization, and Cancer |
| Q36654458 | DNA and histone methylation in gastric carcinogenesis |
| Q33886594 | DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies |
| Q34147851 | DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. |
| Q33581249 | DNA demethylation in normal colon tissue predicts predisposition to multiple cancers |
| Q35870510 | DNA hypo-methylating agents and sickle cell disease |
| Q39923092 | DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. |
| Q35040653 | DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development. |
| Q33862334 | DNA hypomethylation in cancer cells |
| Q37424883 | DNA hypomethylation in the origin and pathogenesis of human diseases |
| Q36341296 | DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis |
| Q64102555 | DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma |
| Q33651436 | DNA methylation and DNA methyltransferases. |
| Q38202821 | DNA methylation and apoptosis resistance in cancer cells |
| Q36395976 | DNA methylation and hydroxymethylation in hematologic differentiation and transformation |
| Q34603514 | DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. |
| Q37940375 | DNA methylation and nonsmall cell lung cancer |
| Q34877480 | DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. |
| Q38528438 | DNA methylation as a molecular biomarker in gastric cancer |
| Q83528971 | DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis |
| Q37072060 | DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment |
| Q38896710 | DNA methylation dynamics in cellular commitment and differentiation |
| Q38086773 | DNA methylation dynamics in health and disease |
| Q35149910 | DNA methylation dynamics in muscle development and disease |
| Q37110130 | DNA methylation in development and human disease |
| Q35729179 | DNA methylation in insects |
| Q26852141 | DNA methylation in mammals |
| Q37259389 | DNA methylation in repetitive elements and post-traumatic stress disorder: a case-control study of US military service members |
| Q90183108 | DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load |
| Q34133706 | DNA methylation of cancer genome. |
| Q57691738 | DNA methylation of mobile genetic elements in human cancers |
| Q53272603 | DNA methylation pattern of the SLC25A43 gene in breast cancer. |
| Q37188534 | DNA methylation patterns in lung carcinomas |
| Q35051119 | DNA methylation predicts recurrence from resected stage III proximal colon cancer |
| Q38650593 | DNA methylation profiles in cancer diagnosis and therapeutics. |
| Q43267407 | DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. |
| Q34477447 | DNA methylation reprogramming in cancer: does it act by re-configuring the binding landscape of Polycomb repressive complexes? |
| Q35647894 | DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology |
| Q33517453 | DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. |
| Q37440102 | DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic development and aging |
| Q58867784 | DNA methylation: A promising target for the twenty-first century |
| Q37232224 | DNA methylation: a marker for carcinogen exposure and cancer risk |
| Q38342368 | DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation |
| Q37597292 | DNA methyltransferases and their roles in tumorigenesis |
| Q36117897 | DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells |
| Q34001042 | DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. |
| Q40453633 | De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine. |
| Q38903814 | Decoupling of DNA methylation and activity of intergenic LINE-1 promoters in colorectal cancer |
| Q34029143 | Decreased LINE-1 methylation levels in aldosterone-producing adenoma |
| Q52719825 | Defining Driver DNA Methylation Changes in Human Cancer. |
| Q35518564 | Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression |
| Q33678040 | Demethylating Agents in the Treatment of Cancer |
| Q36696751 | Demethylation of MAGE promoters during gastric cancer progression |
| Q90669074 | Deregulation of Retroelements as an Emerging Therapeutic Opportunity in Cancer |
| Q33884564 | Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications |
| Q81416192 | Detection and interpretation of altered methylation patterns in cancer cells |
| Q33216402 | Detection and separation of nucleoside-5'-monophosphates of DNA by conjugation with the fluorescent dye BODIPY and capillary electrophoresis with laser-induced fluorescence detection |
| Q37236812 | Development of a universal radioactive DNA methyltransferase inhibition test for high-throughput screening and mechanistic studies |
| Q36619920 | Dietary Intake of One-Carbon Metabolism-Related Nutrients and Pancreatic Cancer Risk: The Singapore Chinese Health Study |
| Q36576975 | Dietary components as epigenetic-regulating agents against cancer |
| Q33954716 | Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer |
| Q21135559 | Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1 |
| Q45169999 | Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer |
| Q29616187 | Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution |
| Q28474736 | Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells |
| Q40595745 | Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers |
| Q47261779 | Disruption of circadian clockwork in in vivo reprogramming-induced mouse kidney tumors. |
| Q39174785 | Dissection of cell cycle-dependent dynamics of Dnmt1 by FRAP and diffusion-coupled modeling. |
| Q34057105 | Distinct epigenomic features in end-stage failing human hearts |
| Q28681397 | Distinct roles of KAP1, HP1 and G9a/GLP in silencing of the two-cell-specific retrotransposon MERVL in mouse ES cells |
| Q53364219 | Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. |
| Q35571255 | Dna methylation in the immune system |
| Q40405040 | Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells |
| Q36232882 | Dnmt1 expression in pre- and postimplantation embryogenesis and the maintenance of IAP silencing |
| Q62057736 | Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia |
| Q28505145 | Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing |
| Q28283633 | Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function |
| Q42373528 | Down-regulation of IFITM1 and its growth inhibitory role in cervical squamous cell carcinoma |
| Q38088774 | Drug discovery using the regulation of gene expression |
| Q34177700 | Dynamic Alu methylation during normal development, aging, and tumorigenesis |
| Q36280490 | Dynamic and reversibility of heterochromatic gene silencing in human disease |
| Q28592823 | Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation |
| Q35849088 | Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation |
| Q37503958 | Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer. |
| Q42444996 | Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation |
| Q27309004 | Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia |
| Q37618202 | Effect of trans-ε-viniferin on in vitro porcine oocyte maturation and subsequent developmental competence in preimplantation embryos |
| Q37179872 | Effects of Sirt1 on DNA methylation and expression of genes affected by dietary restriction |
| Q39467023 | Effects of benzene and its metabolites on global DNA methylation in human normal hepatic L02 cells |
| Q39639196 | Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors |
| Q34407803 | Efficient translation of Dnmt1 requires cytoplasmic polyadenylation and Musashi binding elements |
| Q37455875 | Embryonic stem cells lacking the epigenetic regulator Cfp1 are hypersensitive to DNA-damaging agents and exhibit decreased Ape1/Ref-1 protein expression and endonuclease activity. |
| Q37962013 | Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers |
| Q91619152 | Endogenous retroviruses are associated with hippocampus-based memory impairment |
| Q39769714 | Engineering nicking enzymes that preferentially nick 5-methylcytosine-modified DNA. |
| Q28397621 | Environmental chemical exposures and human epigenetics |
| Q28385295 | Environmental toxicants, epigenetics, and cancer |
| Q34487177 | Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers |
| Q38837858 | Epigenetic Determinants of Cancer |
| Q37438949 | Epigenetic Enhancement of the Post-replicative DNA Mismatch Repair of Mammalian Genomes by a Hemi-(m)CpG-Np95-Dnmt1 Axis |
| Q64076648 | Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity |
| Q47115527 | Epigenetic Regulatory Mechanisms Induced by Resveratrol. |
| Q37830385 | Epigenetic aberrations during oncogenesis. |
| Q92211799 | Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer |
| Q36095721 | Epigenetic alterations in bladder cancer and their potential clinical implications. |
| Q37328845 | Epigenetic alterations in human prostate cancers. |
| Q92590217 | Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles |
| Q28395420 | Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review |
| Q52332848 | Epigenetic alterations to Polycomb targets precede malignant transition in a mouse model of breast cancer. |
| Q39453522 | Epigenetic biomarkers in the diagnosis of ovarian cancer. |
| Q37969665 | Epigenetic cancer therapy: rationales, targets and drugs |
| Q24652017 | Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia |
| Q36086535 | Epigenetic changes in cancer by Raman imaging, fluorescence imaging, AFM and scanning near-field optical microscopy (SNOM). Acetylation in normal and human cancer breast cells MCF10A, MCF7 and MDA-MB-231. |
| Q34385658 | Epigenetic changes in prostate cancer: implication for diagnosis and treatment |
| Q36031457 | Epigenetic changes in response to tai chi practice: a pilot investigation of DNA methylation marks |
| Q36109306 | Epigenetic changes in virus-associated human cancers. |
| Q53335869 | Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention. |
| Q36163349 | Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. |
| Q37941536 | Epigenetic drug discovery: targeting DNA methyltransferases |
| Q38472433 | Epigenetic drugs for cancer treatment and prevention: mechanisms of action |
| Q35974482 | Epigenetic dysregulation in laryngeal squamous cell carcinoma |
| Q57009903 | Epigenetic effects of carbon nanotubes in human monocytic cells |
| Q37600686 | Epigenetic factors in aging and longevity |
| Q38310252 | Epigenetic function of activation-induced cytidine deaminase and its link to lymphomagenesis |
| Q34615086 | Epigenetic hierarchy within the MAGEA1 cancer-germline gene: promoter DNA methylation dictates local histone modifications |
| Q35916788 | Epigenetic inactivation of tumor suppressor genes in hematologic malignancies |
| Q36411144 | Epigenetic instability and chromosomal instability in hepatocellular carcinoma |
| Q34457187 | Epigenetic linkage of aging, cancer and nutrition |
| Q35210734 | Epigenetic mechanisms and genome stability. |
| Q35581063 | Epigenetic mechanisms in developmental programming of adult disease. |
| Q37691486 | Epigenetic mechanisms regulating normal and malignant haematopoiesis: new therapeutic targets for clinical medicine. |
| Q29619753 | Epigenetic modifications and human disease |
| Q37808514 | Epigenetic modifications and human pathologies: cancer and CVD. |
| Q39321339 | Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer. |
| Q37116330 | Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma |
| Q36937745 | Epigenetic programming of mesenchymal stem cells from human adipose tissue |
| Q26796349 | Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis |
| Q53131798 | Epigenetic regulation of DNMT1 gene in mouse model of asthma disease. |
| Q39356240 | Epigenetic regulation of RTK signaling |
| Q34874813 | Epigenetic regulation of cancer-associated genes in ovarian cancer |
| Q33764436 | Epigenetic regulation of epithelial-mesenchymal transition |
| Q36891892 | Epigenetic regulation of estrogen signaling in breast cancer |
| Q37870034 | Epigenetic regulation of gene expression in physiological and pathological brain processes |
| Q40171821 | Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia |
| Q35985447 | Epigenetic reprogramming as a key contributor to melanocyte malignant transformation. |
| Q26753019 | Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential |
| Q34544420 | Epigenetic theories of cancer initiation |
| Q37310619 | Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives. |
| Q36399557 | Epigenetic therapy of cancer: past, present and future |
| Q47356842 | Epigenetic transitions: towards therapeutic targets |
| Q37184917 | Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias |
| Q36579350 | Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation |
| Q38219414 | Epigenetic-based therapies for Friedreich ataxia |
| Q37041763 | Epigenetics and epigenetic alterations in pancreatic cancer. |
| Q28768502 | Epigenetics and human disease: translating basic biology into clinical applications |
| Q28258498 | Epigenetics and its role in male infertility |
| Q36539002 | Epigenetics and the plasticity of differentiation in normal and cancer stem cells |
| Q38457939 | Epigenetics in lung cancer diagnosis and therapy |
| Q33835721 | Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium |
| Q37571067 | Epigenetics of endometriosis |
| Q37887493 | Epigenetics of haematopoietic cell development |
| Q28730790 | Epigenetics: connecting environment and genotype to phenotype and disease |
| Q34051535 | Epigenome Mapping in Normal and Disease States |
| Q33739319 | Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis |
| Q33942280 | Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors |
| Q35711392 | Epigenomics of ovarian cancer and its chemoprevention |
| Q35778671 | Epigenomics: beyond CpG islands. |
| Q37265022 | Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas |
| Q51347223 | Evaluation of the global DNA methylation in canine mast cell tumour samples by immunostaining of 5-methyl cytosine. |
| Q37082758 | Evidence for a novel mechanism for gene amplification in multiple myeloma: 1q12 pericentromeric heterochromatin mediates breakage-fusion-bridge cycles of a 1q12 approximately 23 amplicon |
| Q28678232 | Evolution of the cancer genome |
| Q35111866 | Examination of whole blood DNA methylation as a potential risk marker for gastric cancer |
| Q37080366 | Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer |
| Q33743601 | Expression of t-DARPP mediates trastuzumab resistance in breast cancer cells |
| Q34310997 | Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer |
| Q36610921 | Foetal haemoglobin-blood cells (F-cells) as a feature of embryonic tumours (blastomas). |
| Q33756188 | Folate deficiency as predisposing factor for childhood leukaemia: a review of the literature. |
| Q37088253 | Folate deficiency induces genomic uracil misincorporation and hypomethylation but does not increase DNA point mutations |
| Q34478743 | Folate deficiency regulates expression of DNA polymerase β in response to oxidative stress |
| Q36230469 | Frequent expression of MAGE1 tumor antigens in bronchial epithelium of smokers without lung cancer |
| Q38472616 | Functional aspects of cytidine-guanosine dinucleotides and their locations in genes |
| Q36930975 | Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist |
| Q33725090 | Functional interaction between co-expressed MAGE-A proteins |
| Q34550628 | Future potential of the Human Epigenome Project |
| Q34557714 | Gemifloxacin for the treatment of respiratory tract infections: in vitro susceptibility, pharmacokinetics and pharmacodynamics, clinical efficacy, and safety |
| Q39821204 | Gene expression pattern and downregulation of DNA methyltransferase 1 using siRNA in porcine somatic cells |
| Q40830535 | Genes and transposons are differentially methylated in plants, but not in mammals |
| Q40047438 | Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma |
| Q37070978 | Genetic signature for human risk assessment: lessons from trichloroethylene |
| Q47177866 | Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival |
| Q36497718 | Genetically engineered mouse models in cancer research |
| Q37101724 | Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas |
| Q41101024 | Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis |
| Q37962581 | Genome-wide DNA methylation in human heart failure. |
| Q28391482 | Genome-wide analysis in human colorectal cancer cells reveals ischemia-mediated expression of motility genes via DNA hypomethylation |
| Q64956137 | Genome-wide hypomethylation of LINE-1 and Alu retroelements in cell-free DNA of blood is an epigenetic biomarker of human aging. |
| Q35339140 | Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma |
| Q34122286 | Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. |
| Q33242598 | Genomic alterations in ectopic and eutopic endometria of women with endometriosis |
| Q38497589 | Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm |
| Q34277089 | Genomic hypomethylation in the human germline associates with selective structural mutability in the human genome |
| Q38382440 | Genomic instability: Crossing pathways at the origin of structural and numerical chromosome changes |
| Q36398297 | Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women |
| Q36606069 | Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer |
| Q90662533 | Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability |
| Q37266816 | Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. |
| Q53263685 | Global DNA hypomethylation coupled to cellular transformation and metastatic ability. |
| Q34539547 | Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk |
| Q48071382 | Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma. |
| Q64056571 | Global DNA methylation of peripheral blood leukocytes from dogs bearing multicentric non-Hodgkin lymphomas and healthy dogs: A comparative study |
| Q34142428 | Global analysis of DNA methylation in early-stage liver fibrosis |
| Q54287191 | Global demethylation in loss of imprinting subtype of Wilms tumor. |
| Q33519525 | Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity |
| Q37962571 | Global epigenetic profiling in bladder cancer. |
| Q81007919 | Global increase in DNA methylation in patients with myelodysplastic syndrome |
| Q90705372 | Glyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent Manner |
| Q24564106 | Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG |
| Q35788928 | Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains |
| Q38175087 | Harnessing the potential of epigenetic therapy to target solid tumors. |
| Q92189808 | Helicase Lymphoid-Specific Enzyme Contributes to the Maintenance of Methylation of SST1 Pericentromeric Repeats That Are Frequently Demethylated in Colon Cancer and Associate with Genomic Damage |
| Q38484630 | High resolution integrative analysis reveals widespread genetic and epigenetic changes after chronic in-vitro acid and bile exposure in Barrett's epithelium cells |
| Q36423456 | High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer |
| Q28513000 | Histone H3-K9 methyltransferase ESET is essential for early development |
| Q37331641 | Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice |
| Q40022345 | Holocarboxylase synthetase interacts physically with euchromatic histone-lysine N-methyltransferase, linking histone biotinylation with methylation events |
| Q42551273 | Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats |
| Q28661652 | Human GMDS gene fragment hypermethylation in chronic high level of arsenic exposure with and without arsenic induced cancer |
| Q27010001 | Human transposon tectonics |
| Q40136348 | Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). |
| Q24305082 | Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer |
| Q37446488 | Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis |
| Q37961724 | Hypomethylation of repeated DNA sequences in cancer. |
| Q39977133 | Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype |
| Q91584734 | Identification of core differentially methylated genes in glioma |
| Q34181789 | Identification of driver and passenger DNA methylation in cancer by epigenomic analysis |
| Q28238147 | Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling |
| Q38335531 | Identification of novel Myc target genes with a potential role in lymphomagenesis |
| Q58101947 | Idiopathic male infertility is strongly associated with aberrant DNA methylation of imprinted loci in sperm: a case-control study |
| Q36386448 | Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes. |
| Q55262096 | Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients. |
| Q33996334 | Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components |
| Q24306181 | Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 |
| Q33914622 | In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation |
| Q40448471 | Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. |
| Q37812563 | Induced pluripotent cancer cells: progress and application |
| Q26801711 | Induced pluripotent stem cell technology for dissecting the cancer epigenome |
| Q35571293 | Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. |
| Q39709698 | Insights into the role of DNA methylation in disease through the use of mouse models |
| Q36001915 | Insufficient DNA methylation affects healthy aging and promotes age-related health problems |
| Q48375750 | Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures. |
| Q35919690 | Integrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes |
| Q90705746 | Integrated genomic and methylation profile analysis to identify candidate tumor marker genes in patients with colorectal cancer |
| Q28077579 | Integrating Epigenomics into the Understanding of Biomedical Insight |
| Q36152246 | Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer |
| Q37550690 | Interaction with the DNA Repair Protein Thymine DNA Glycosylase Regulates Histone Acetylation by p300. |
| Q24658370 | Intra-individual change over time in DNA methylation with familial clustering |
| Q38715367 | Intragenic DNA methylation prevents spurious transcription initiation |
| Q36854908 | Intratumoral Heterogeneity of the Epigenome. |
| Q58753393 | Ionizing Radiation and Human Health: Reviewing Models of Exposure and Mechanisms of Cellular Damage. An Epigenetic Perspective |
| Q82799816 | Irradiation induces DNA damage and modulates epigenetic effectors in distant bystander tissue in vivo |
| Q39233074 | Is DNA methylation the new guardian of the genome? |
| Q39805891 | Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter |
| Q35839338 | Kinetics of DNA methylation inheritance by the Dnmt1-including complexes during the cell cycle. |
| Q24799489 | L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas |
| Q42908408 | LINE-1 activation and epigenetic silencing of suppressor genes in cancer: Causally related events? |
| Q33886421 | LINE-1 hypomethylation during primary colon cancer progression |
| Q33283510 | LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability |
| Q37298707 | LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis |
| Q54302136 | LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history. |
| Q37070832 | LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. |
| Q33550560 | LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor |
| Q41699788 | LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas |
| Q39325725 | LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review |
| Q34294473 | LINE-1 methylation status and its association with tetralogy of fallot in infants |
| Q53345314 | Lack of correlation between DNA copy number and mRNA expression levels of c-myc in gamma-radiation-induced mouse thymic lymphomas by using quantitative real-time PCR. |
| Q42960321 | Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate |
| Q42186756 | Large-scale structure of genomic methylation patterns |
| Q37079680 | Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. |
| Q36001900 | Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications |
| Q44885739 | Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. |
| Q53110472 | Loss of Dnmt3b accelerates MLL-AF9 leukemia progression. |
| Q28589092 | Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis |
| Q36064770 | Low-level environmental cadmium exposure is associated with DNA hypomethylation in Argentinean women |
| Q28505283 | Lsh is involved in de novo methylation of DNA |
| Q24297439 | MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents |
| Q31150120 | MBD2 deficiency does not accelerate p53 mediated lymphomagenesis |
| Q81672675 | MLL methylation is not likely a common mechanism for therapy-related AML |
| Q24810367 | MSRE-PCR for analysis of gene-specific DNA methylation |
| Q38747872 | Marked for death: targeting epigenetic changes in cancer |
| Q92634851 | Maternal Exposure to High-Fat Diet Induces Long-Term Derepressive Chromatin Marks in the Heart |
| Q34611930 | Maternal transmission of a humanised Igf2r allele results in an Igf2 dependent hypomorphic and non-viable growth phenotype |
| Q36671608 | MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status |
| Q41968239 | Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer |
| Q36803783 | Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer |
| Q26861785 | Mechanisms of epigenetic regulation of leukemia onset and progression |
| Q35945177 | Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma |
| Q73456178 | Meddling with methylation |
| Q33847875 | Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation |
| Q37620965 | Methods for genome-wide analysis of DNA methylation in intestinal tumors |
| Q33893167 | Methods in DNA methylation profiling |
| Q35169101 | Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells. |
| Q36913739 | Methylated DNA and microRNA in body fluids as biomarkers for cancer detection. |
| Q36891370 | Methylated DNA sequences for early cancer detection, molecular classification and chemotherapy response prediction |
| Q64227434 | Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? |
| Q58695648 | Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women |
| Q37040644 | Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer |
| Q52895027 | Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer. |
| Q40019764 | Methylation perturbations in retroelements within the genome of a Mus interspecific hybrid correlate with double minute chromosome formation. |
| Q36076351 | Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma |
| Q36076356 | Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis |
| Q24795636 | Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma |
| Q47323579 | Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis |
| Q80805160 | Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation |
| Q35208036 | Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance |
| Q37238372 | MiRNAs, epigenetics, and cancer |
| Q38306947 | MicroRNA regulatory networks in idiopathic pulmonary fibrosis. |
| Q30988873 | Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors |
| Q33267829 | Mining methylation for early detection of common cancers |
| Q31081839 | Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells |
| Q28259737 | Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients |
| Q34621450 | Modifiers of epigenetic reprogramming show paternal effects in the mouse. |
| Q34790860 | Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study |
| Q53612758 | Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation. |
| Q60955182 | Molecular Mechanisms Underlying the Link between Diet and DNA Methylation |
| Q38133084 | Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine |
| Q37533620 | Molecular epigenetics and genetics in neuro-oncology |
| Q37702543 | Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise? |
| Q38598168 | Monitoring Dynamics of DNA Methylation at Single-Cell Resolution during Development and Disease |
| Q35124378 | Multiple sporadic colorectal cancers display a unique methylation phenotype |
| Q36628683 | Multistep carcinogenesis of the colon in Apc(Min/+) mouse |
| Q45866784 | Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells |
| Q54574818 | Mutations galore in myeloproliferative neoplasms: would the real Spartacus please stand up? |
| Q38150711 | Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer |
| Q39069897 | Mutual regulation of microRNAs and DNA methylation in human cancers |
| Q36848353 | Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer |
| Q35699435 | Notes on the role of dynamic DNA methylation in mammalian development |
| Q92890341 | Novel genes exhibiting DNA methylation alterations in Korean patients with chronic lymphocytic leukaemia: a methyl-CpG-binding domain sequencing study |
| Q39800607 | Novel risk markers for gastric cancer screening: Present status and future prospects |
| Q36617731 | Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? |
| Q53335948 | Oestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women. |
| Q37629350 | On form and function: does chromatin packing regulate the cell cycle? |
| Q64078658 | On the Complexity of Mechanisms and Consequences of Chromothripsis: An Update |
| Q38020424 | On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape |
| Q37634314 | Oncoviruses and Pathogenic MicroRNAs in Humans |
| Q35867147 | One-Carbon Metabolism and Colorectal Cancer: Potential Mechanisms of Chemoprevention |
| Q34016094 | Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis |
| Q42107433 | Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer |
| Q33356247 | Optical mapping discerns genome wide DNA methylation profiles |
| Q39627734 | Organomegaly and tumors in transgenic mice with targeted expression of HpaII methyltransferase in smooth muscle cells |
| Q35998526 | Overexpression of DNA damage-induced 45 α gene contributes to esophageal squamous cell cancer by promoter hypomethylation |
| Q28554451 | Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation |
| Q35620200 | Overlapping DNA methylation dynamics in mouse intestinal cell differentiation and early stages of malignant progression |
| Q92351733 | Paradoxical association of TET loss of function with genome-wide DNA hypomethylation |
| Q33415064 | Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity |
| Q29614515 | Phenotypic plasticity and the epigenetics of human disease |
| Q28384560 | Placental DNA hypomethylation in association with particulate air pollution in early life |
| Q34955668 | Plasma S-adenosylmethionine, DNMT polymorphisms, and peripheral blood LINE-1 methylation among healthy Chinese adults in Singapore |
| Q53212651 | Point mutation instability (PIN) mutator phenotype as model for true back mutations seen in hereditary tyrosinemia type 1 - a hypothesis. |
| Q37313424 | Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy |
| Q26798810 | Potential of adipose-derived stem cells in muscular regenerative therapies |
| Q33525767 | Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells |
| Q36109663 | Predicting the effect of transcription therapy in hematologic malignancies |
| Q34437941 | Prediction of methylated CpGs in DNA sequences using a support vector machine |
| Q36211310 | Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status |
| Q64053408 | Prenatal epigenetics diets play protective roles against environmental pollution |
| Q48674846 | Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT). |
| Q36008593 | Procainamide is a specific inhibitor of DNA methyltransferase 1. |
| Q35571288 | Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg |
| Q55381984 | Prognostic value of LINE-1 methylation level in 321 patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. |
| Q38660226 | Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells |
| Q83318087 | Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome |
| Q36696681 | Promoter hypermethylation of MGMT, CDH1, RAR-beta and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin |
| Q44500993 | Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia |
| Q46446472 | Promoter hypomethylation regulates CD133 expression in human gliomas |
| Q38895486 | Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome. |
| Q34182555 | Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells |
| Q36535688 | Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level |
| Q33864173 | Proximity ligation in situ assay for monitoring the global DNA methylation in cells |
| Q36189555 | RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation |
| Q28239828 | RGS6 interacts with DMAP1 and DNMT1 and inhibits DMAP1 transcriptional repressor activity |
| Q51848749 | RNA-directed epigenomic reprogramming: an emerging principle of a more targeted cancer therapy? |
| Q36666502 | Radioadaptive response revisited. |
| Q36090058 | Recent advances in molecular diagnosis and therapy of gastric cancer |
| Q36941312 | Recreational and household physical activity at different time points and DNA global methylation. |
| Q33217127 | Recruitment of DNA methyltransferase I to DNA repair sites |
| Q27851629 | Recurrent DNMT3A mutations in patients with myelodysplastic syndromes |
| Q41841980 | Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic mice |
| Q24536144 | Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis |
| Q34384312 | Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet. |
| Q38879235 | Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation |
| Q35020444 | Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice |
| Q35153140 | Regulation and function of DNA methylation in plants and animals. |
| Q37217178 | Regulation of CpG methylation by Dnmt and Tet in pluripotent stem cells |
| Q37220124 | Regulation of pluripotency in male germline stem cells by Dmrt1. |
| Q38911676 | Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer. |
| Q92341929 | Regulation of transposable elements by DNA modifications |
| Q41420061 | Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae |
| Q39639045 | Repeat-element driven activation of proto-oncogenes in human malignancies |
| Q37119615 | Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study |
| Q42931458 | Replication stress, a source of epigenetic aberrations in cancer? |
| Q34398115 | Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus |
| Q37521263 | Reprogramming of a melanoma genome by nuclear transplantation |
| Q28067369 | Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms |
| Q26797512 | Response of transposable elements to environmental stressors |
| Q24813212 | Restricted mobility of Dnmt1 in preimplantation embryos: implications for epigenetic reprogramming |
| Q61759292 | Retrotransposon-Driven Transcription and Cancer |
| Q37129860 | Retrotransposon-encoded reverse transcriptase in the genesis, progression and cellular plasticity of human cancer. |
| Q38341003 | Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis |
| Q38071897 | Review of the alterations in DNA methylation in esophageal squamous cell carcinoma |
| Q38895216 | Rewiring the solid tumor epigenome for cancer therapy |
| Q37810062 | Role of epigenetic therapy in myelodysplastic syndrome |
| Q36459023 | Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression |
| Q36155532 | Role of nuclear architecture in epigenetic alterations in cancer |
| Q33697456 | Roles of retrotransposons in benign and malignant hematologic disease |
| Q39056256 | Senescent cells harbour features of the cancer epigenome. |
| Q35916111 | Sensitive quantitative analysis of murine LINE1 DNA methylation using high resolution melt analysis. |
| Q34687656 | Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk. |
| Q28384337 | Short-term diesel exhaust inhalation in a controlled human crossover study is associated with changes in DNA methylation of circulating mononuclear cells in asthmatics |
| Q33978878 | Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis |
| Q50729608 | Sleeping Beauty transposition in the mouse genome is associated with changes in DNA methylation at the site of insertion. |
| Q38383972 | Sodium bisulfite pyrosequencing revealed that developmental exposure to environmental contaminant mixtures does not affect DNA methylation of DNA repeats in Sprague-Dawley rats |
| Q50504208 | Soma to germline inheritance of extrachromosomal genetic information via a LINE-1 reverse transcriptase-based mechanism. |
| Q35694210 | Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer |
| Q24657343 | Specific gene hypomethylation and cancer: new insights into coding region feature trends |
| Q43152208 | Specific in vivo expression in type II pneumocytes of the Jaagsiekte sheep retrovirus long terminal repeat in transgenic mice |
| Q37056726 | Specific inhibition of one DNMT1-including complex influences tumor initiation and progression. |
| Q49956187 | Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma. |
| Q45866358 | Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority |
| Q37857056 | Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. |
| Q35749932 | Structure and function of eukaryotic DNA methyltransferases |
| Q37829700 | Structure and function of mammalian DNA methyltransferases. |
| Q47751941 | Study on the Interaction of the CpG Alternating DNA with CdTe Quantum Dots |
| Q37301148 | Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate. |
| Q34563186 | Suppression of intestinal neoplasia by deletion of Dnmt3b |
| Q42973524 | Suppressive effect of global DNA hypomethylation on gastric carcinogenesis |
| Q38814744 | Sézary Syndrome: Clinical and Biological Aspects |
| Q36197509 | TET proteins and 5-methylcytosine oxidation in hematological cancers |
| Q89848688 | TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion |
| Q34445845 | TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway |
| Q90429907 | Targeting DNA Hypomethylation in Malignancy by Epigenetic Therapies |
| Q36150848 | Targeting epigenetic regulatory mechanisms in cancer chemoprevention |
| Q33890546 | Targeting the epigenome in malignant pleural mesothelioma |
| Q28511594 | Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice |
| Q35025083 | Testing gene function early in the B cell lineage in mb1-cre mice |
| Q36673761 | The 'de novo' DNA methyltransferase Dnmt3b compensates the Dnmt1-deficient intestinal epithelium. |
| Q34772160 | The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies |
| Q37029584 | The Aging Epigenome |
| Q35702082 | The Association of LINE-1 Hypomethylation with Age and Centromere Positive Micronuclei in Human Lymphocytes |
| Q42364239 | The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks |
| Q33750243 | The DNA methylome of human peripheral blood mononuclear cells |
| Q36063358 | The Daxx/Atrx Complex Protects Tandem Repetitive Elements during DNA Hypomethylation by Promoting H3K9 Trimethylation |
| Q35571262 | The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease |
| Q58789495 | The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting |
| Q28507079 | The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin |
| Q41923596 | The REMOTE-control system: a system for reversible and tunable control of endogenous gene expression in mice |
| Q64108233 | The Roles of Human DNA Methyltransferases and Their Isoforms in Shaping the Epigenome |
| Q40262798 | The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation |
| Q44737509 | The absence of p53 is critical for the induction of apoptosis by 5-aza-2'-deoxycytidine |
| Q36109310 | The altered DNA methylation pattern and its implications in liver cancer |
| Q37911496 | The application of delivery systems for DNA methyltransferase inhibitors |
| Q35207554 | The application of functional genomics to Alzheimer's disease |
| Q52902095 | The enemy within: an epigenetic role of retrotransposons in cancer initiation. |
| Q39021700 | The epigenetic landscape of renal cancer |
| Q29617486 | The epigenetic progenitor origin of human cancer |
| Q34310378 | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| Q36252000 | The epigenome as a molecular marker and target |
| Q29617273 | The history of cancer epigenetics |
| Q36286073 | The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases |
| Q38063931 | The methylation landscape of tumour metastasis |
| Q45792913 | The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance |
| Q33698033 | The new field of epigenomics: implications for cancer and other common disease research. |
| Q33782233 | The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer |
| Q37903980 | The potential role of epigenetic responses to diet in ageing |
| Q38673415 | The potential role of retroviruses in autoimmunity |
| Q44294975 | The promise of epigenetic therapies in treatment of idiopathic pulmonary fibrosis |
| Q36955040 | The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines |
| Q33911063 | The regulation of non-coding RNA expression in the liver of mice fed DDC. |
| Q35589077 | The rise and fall of genomic methylation in cancer. |
| Q51205890 | The role of DNA methylation in ST6Gal1 expression in gliomas. |
| Q52692099 | The role of DNA methylation in ageing and cancer. |
| Q28247253 | The role of epigenetic inactivation of 14-3-3sigma in human cancer |
| Q36066276 | The silence of the genes: epigenetic disturbances in haematopoietic malignancies |
| Q36943376 | The stem cell identity of testicular cancer |
| Q46570903 | The wayward methyl group and the cascade to cancer |
| Q24309357 | Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair |
| Q89634808 | Tissue and cancer-specific expression of DIEXF is epigenetically mediated by an Alu repeat |
| Q89076128 | Tissue-specific DNA methylation loss during ageing and carcinogenesis is linked to chromosome structure, replication timing and cell division rates |
| Q57239936 | Towards defining the lymphoma methylome |
| Q40584357 | Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. |
| Q55260615 | Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics. |
| Q99248345 | Transgenerational inheritance of impaired larval T cell development in zebrafish |
| Q35840178 | Transgenic mice as an in vivo model of lymphomagenesis |
| Q40312232 | Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells |
| Q46717074 | Trapped in action: direct visualization of DNA methyltransferase activity in living cells. |
| Q35034880 | Treatment with 5-azacytidine accelerates acute promyelocytic leukemia leukemogenesis in a transgenic mouse model. |
| Q35812510 | Trials, tribulations, and trends in tumor modeling in mice |
| Q37688202 | Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival |
| Q34169734 | Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis |
| Q35795835 | Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design |
| Q39637175 | Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α. |
| Q37666328 | Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies |
| Q37632823 | UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma |
| Q37628934 | UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma |
| Q34983911 | Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma |
| Q28591019 | Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1 |
| Q38122355 | Virion factors that target Daxx to overcome intrinsic immunity. |
| Q30244255 | Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer. |
| Q34183426 | Whole genome DNA methylation signature of HER2-positive breast cancer |
| Q59134234 | and Methylation Attenuates Tubulin Expression and Cell Stiffness in Cancer |
| Q24301278 | p66alpha and p66beta of the Mi-2/NuRD complex mediate MBD2 and histone interaction |
Search more.